Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan

Chinese Journal of Physiology

Volumn 54, Issue 3, 2011, Pages 7-

  Lin, Hui Hui ^a,b   Ke, Hung Lung ^a,c   Hsiao, Kuang Hung ^a,b   Tsai, Chia Wen ^d   Wu, Wen Jeng ^a,c   Bau, Da Tian ^d,e   Chang, Lin Li ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bladder cancer; CCND1 G870A; Cyclin D1; Polymorphism; Upper tract urothelial cancer; Urothelial carcinoma

Indexed keywords

CYCLIN D1; TUMOR MARKER; CCND1 PROTEIN, HUMAN;

ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; INVASIVE CARCINOMA; MUSCLE METASTASIS; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PREDICTION; PROGNOSIS; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; TRANSITIONAL CELL CARCINOMA; ASIAN; BLADDER TUMOR; CANCER INVASION; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; CYCLIN D1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NEOPLASM INVASIVENESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TAIWAN; URINARY BLADDER NEOPLASMS;

EID: 79954484141     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2011.AMM123     Document Type: Article

References (34)

1. Bau, D.T., Wang, H.C., Liu, C.S., Chang, C.L., Chiang, S.Y., Wang, R.F., Tsai, C.W., Lo, Y.L., Hsiung, C.A., Lin, C.C. and Huang, C.Y. Single-nucleotide polymorphism of the Exo1 gene: association with gastric cancer susceptibility and interaction with smoking in Taiwan. Chinese J. Physiol. 52: 411-418, 2009.
2. Bau, D.T. Hsieh, Y.Y., Wan, L., Wang, R.F., Liao, C.C., Lee, C.C., Lin, C.C., Tsai, C.H. and Tsai, F. J. Polymorphism of XRCC1 codon arg 399 Gln is associated with higher susceptibility to endometriosis. Chinese J. Physiol. 50: 326-329, 2007.
3. Bau, D.T., Tsai, M.H., Huang, C.Y., Lee, C.C., Tseng, H.C., Lo, Y.L., Tsai, Y. and Tsai, F.J. Relationship between polymorphisms of nucleotide excision repair genes and oral cancer risk in Taiwan: evidence for modification of smoking habit. Chinese J. Physiol.50: 294-300, 2007.
4. Betticher, D.C., Thatcher, N., Altermatt, H.J., Hoban, P., Ryder, W. D. and Heighway, J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11: 1005-1011, 1995.
5. Burch, J.D., Rohan, T.E., Howe, G.R., Risch, H.A., Hill, G.B., Steele, R. and Miller, A.B. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int. J. Cancer 44: 622-628, 1989.
6. Chang, L.L., Yeh, W.T., Yang, S.Y., Wu, W.J. and Huang, C.H. Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer. J. Urol. 170: 595-600, 2003.
7. Chen, C.J., Hsueh, Y.M., Lai, M.S., Shyu, M.P., Chen, S.Y., Wu, M.M., Kuo, T.L. and Tai, T.Y. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25: 53-60, 1995.
8. Chou, Y.H. and Huang, C.H. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer 85: 1342-1344, 1999.
9. Cortessis, V.K., Siegmund, K., Xue, S., Ross, R.K. and Yu, M.C. A case-control study of cyclin D1 CCND1 870A-→G polymorphism and bladder cancer. Carcinogenesis 24: 1645-1650, 2003.
10. Epstein, J.I., Amin, M.B., Reuter, V.R. and Mostofi, F.K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 22: 1435-1448, 1998.
11. Gangwar, R. and Mittal, R.D. Association of selected variants in genes involved in cell cycle and apoptosis with bladder cancer risk in north india population. DNA Cell Biol. 29: 349-356, 1986.
12. Greene, F.L., Page, D.L. and Fleming, I. D. AJCC Cancer Staging Manual, 6 ed. Springer-Verlag, New York, 2002.
13. Hirao, Y., Kim, W.J. and Fujimoto, K. Environmental factors promoting bladder cancer. Curr. Opin. Urol. 19: 494-499, 2009.
14. Ito, M., Habuchi, T., Watanabe, J., Higashi, S., Nishiyama, H., Wang, L., Tsuchiya, N., Kamoto, T. and Ogawa, O. Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer. Urology 64: 74-78, 2004.
15. Jemal, A., Tiwari, R.C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E.J. and Thun, M.J. Cancer statistics, 2004. CA. Cancer. J. Clin. 54: 8-29, 2004.
16. Knudsen, K.E., Diehl, J.A., Haiman, C.A. and Knudsen, E.S. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25: 1620-1628, 2006.
17. Larsson, P., Wijkstrom, H., Thorstenson, A., Adolfsson, J., Norming, U., Wiklund, P., Onelov, E. and Steineck, G. A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years. Scand. J. Urol. Nephrol. 37: 195-201, 2003.
18. Lee, C.C., Yamamoto, S., Morimura, K., Wanibuchi, H., Nishisaka, N., Ikemoto, S., Nakatani, T., Wada, S., Kishimoto, T. and Fukushima, S. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer 79: 780-789, 1997.
19. Liaw, K.L., Linet, M.S., McLaughlin, J.K., Yu, M.C., Schoenberg, J.B., Lynch, C.F., Niwa, S. and Fraumeni, J.F., Jr. Possible relation between hypertension and cancers of the renal pelvis and ureter. Int. J. Cancer 70: 265-268, 1997.
20. Linet, M.S., Chow, W.H., McLaughlin, J.K., Wacholder, S., Yu, M.C., Schoenberg, J.B., Lynch, C. and Fraumeni, J.F., Jr. Analgesics and cancers of the renal pelvis and ureter. Int. J. Cancer 62: 15-18, 1995.
21. Mahony, J.F., Storey, B.G., Ibanez, R.C. and Stewart, J.H. Analgesic abuse, renal parenchymal disease and carcinoma of the kidney or ureter. Aust. N. Z. J. Med. 7: 463-469, 1977.
22. McLaughlin, J.K., Silverman, D.T., Hsing, A.W., Ross, R.K., Schoenberg, J.B., Yu, M.C., Stemhagen, A., Lynch, C.F., Blot, W.J. and Fraumeni, J.F., Jr. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res. 52: 254-257, 1992.
23. Mellemgaard, A., Carstensen, B., Norgaard, N., Knudsen, J.B. and Olsen, J.H. Trends in the incidence of cancer of the kidney, pelvis, ureter and bladder in Denmark 1943-88. Scand. J. Urol. Nephrol.27: 327-332, 1993.
24. Reznikoff, C.A., Sarkar, S., Julicher, K.P., Burger, M.S., Puthenveettil, J.A., Jarrard, D.F. and Newton, M.A. Genetic alterations and biological pathways in human bladder cancer pathogenesis. Urol. Oncol. 5: 191-203, 2000.
25. Rogers, S., Wells, R. and Rechsteiner, M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234: 364-368, 1986.
26. Sanyal, S., Festa, F., Sakano, S., Zhang, Z., Steineck, G., Norming, U., Wijkstrom, H., Larsson, P., Kumar, R. and Hemminki, K. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25: 729-734, 2004.
27. Sgambato, A., Migaldi, M., Faraglia, B., De Aloysio, G., Ferrari, P., Ardito, R., De Gaetani, C., Capelli, G., Cittadini, A. and Trentini, G.P. Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome. Int. J. Cancer 97: 671-678, 2002.
28. Shin, K.Y., Kong, G., Kim, W.S., Lee, T.Y., Woo, Y.N. and Lee, J.D. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers. Br. J. Cancer 75: 1788-1792, 1997.
29. Stacey, D.W. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr. Opin. Cell Biol. 15: 158-163, 2003.
30. Suwa, Y., Takano, Y., Iki, M., Takeda, M., Asakura, T., Noguchi, S. and Masuda, M. Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder. J. Urol.160: 897-900, 1998.
31. Wang, L., Habuchi, T., Takahashi, T., Mitsumori, K., Kamoto, T., Kakehi, Y., Kakinuma, H., Sato, K., Nakamura, A., Ogawa, O. and Kato, T. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. 23: 257-264, 2002.
32. Williams, C.B. and Mitchell, J.P. Carcinoma of the ureter-a review of 54 cases. Br. J. Urol. 45: 377-387, 1973.
33. Yang, C.H., Hung, W.C., Wang, S.L., Kang, W.Y., Chen, W.T., Huang, Y.C., Su, Y.C. and Chai, C.Y. Immunoexpression and prognostic role of hTERT and cyclin D1 in urothelial carcinoma. APMIS 116: 309-316, 2008.
34. Yuan, L., Gu, X., Shao, J., Wang, M., Zhu, Q. and Zhang, Z. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer. DNA Cell Biol. 29: 611-617, 2010.